We explain this result by the fact that CuMVs can modulate ROS production and the expression of superoxide dismutase (SOD1) in recipient macrophages, thus preventing the transition of M2 macrophages into TAMs (tumor-associated macrophages) [26]. The gene discussed is SOD1; the disease is neoplasm.